CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · Executive or director change · Bylaws or fiscal year change · Other events
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Exit or restructuring costs
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Exit or restructuring costs
- 8-K Event Other events
- 8-K Event Other events
- 4 Open-market sale CFO sold 1,380 shares at $0.57 ($787)
- 8-K Event Delisting notice
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- 4 Open-market sale EVP, CMO sold 1,437 shares at $1.03 ($1,473)
- 4 Open-market sale President and CEO sold 4,856 shares at $1.03 ($4,979)
- 8-K Event Executive or director change · Shareholder vote results
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 32 of 68 · 1,358 filings